These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37688931)

  • 41. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.
    Viel JF; Rymzhanova R; Fournier E; Danzon A
    Cancer Epidemiol; 2011 Dec; 35(6):521-5. PubMed ID: 21621498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.
    Broeders MJM; Allgood P; Duffy SW; Hofvind S; Nagtegaal ID; Paci E; Moss SM; Bucchi L
    BMC Cancer; 2018 Sep; 18(1):860. PubMed ID: 30176813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends in breast cancer by race and ethnicity: update 2006.
    Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
    CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.
    Song QK; Wang XL; Zhou XN; Yang HB; Li YC; Wu JP; Ren J; Lyerly HK
    Oncologist; 2015 Jul; 20(7):773-9. PubMed ID: 26001390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should we use incidence, survival or mortality to assess breast cancer trends in European women?
    Sant M; Francisci S; Capocaccia R; Verdecchia A; Allemani C; Berrino F
    Nat Clin Pract Oncol; 2006 May; 3(5):228-9. PubMed ID: 16682983
    [No Abstract]   [Full Text] [Related]  

  • 47. [Attendance of the fourth (2008-2009) screening round of the Hungarian organized, nationwide breast cancer screening program].
    Boncz I; Döbrőssy L; Péntek Z; Kovács A; Budai A; Imre L; Vajda R; Sebestyén A
    Orv Hetil; 2013 Dec; 154(50):1975-83. PubMed ID: 24317356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy.
    Buiatti E; Barchielli A; Bartolacci S; Bucchi L; De LV; Federico M; Ferretti S; Paci E; Vettorazzi M; Zanetti R;
    Cancer Causes Control; 2002 Feb; 13(1):65-71. PubMed ID: 11899119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Screening for breast cancer: worries about its effectiveness].
    Autier P
    Rev Prat; 2013 Dec; 63(10):1369-77. PubMed ID: 24579331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
    Niraula S; Biswanger N; Hu P; Lambert P; Decker K
    JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in breast cancer mortality in Sweden before and after implementation of mammography screening.
    Haukka J; Byrnes G; Boniol M; Autier P
    PLoS One; 2011; 6(9):e22422. PubMed ID: 21966354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current status and goals of mammographic screening for breast cancer in Japan.
    Morimoto T; Okazaki M; Endo T
    Breast Cancer; 2004; 11(1):73-81. PubMed ID: 14718797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of three decades of screening mammography on breast-cancer incidence.
    Bleyer A; Welch HG
    N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
    Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
    Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study.
    Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chiu SY; Chen SL; Jen GH; Ku MM; Hsu CY; Ahlgren J; Maroni R; Holmberg L; Chen TH
    Radiology; 2021 Jun; 299(3):541-547. PubMed ID: 33650900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of mammography screening regimen on incidence-based breast cancer mortality.
    Yaffe MJ; Mittmann N; Alagoz O; Trentham-Dietz A; Tosteson AN; Stout NK
    J Med Screen; 2018 Dec; 25(4):197-204. PubMed ID: 30049249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.